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ABSTRACT: The objectives of this investigation were to evaluate the release of
dihydrotestosterone (DHT) from nonimpregnated and poly(lactic acid) (PLA)
impregnated ALCAP ceramic reservoirs implanted in male rats, and to study
the effects of delivered DHT on the reproductive system of male rats. A total of
120 Sprague-Dawley male albino rats were distributed equally into three
groups. Two ALCAP capsules, one nonimpregnated and the other impregnated
with PLA, were implanted in each rat in groups I and II. Capsules implanted
in group I rats were loaded with 40 mg DHT each. Group II rats were implanted
with two empty capsules (sham group), and group III animals served as un-
implanted controls. Eight rats from each group were euthanized at the end of
the one, three, six, nine, and twelve months following the implantation of the
ceramics. No significant changes in the weights of vital organs of rats were
observed among any of the three different groups. Vas deferens and epididymal
fluid were devoid of normal spermatozoa within three months of implanting the
steroid-containing ceramics. Testes weights decreased significantly in the rats
implanted with ALCAP ceramics containing DHT and the seminiferous
tubules became oligospermic after one month and azoospermic after three
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months. The data collected in this study suggest that: (1) ALCAP ceramic cap-
sules are capable of delivering DHT for one year at a sustained manner; (2)
DHT delivered by ALCAP capsules can be used effectively to regulate sperma-
togenesis in rats.
INTRODUCTION
onsiderable evidence has accumulated during the past few years toC indicate that dihydrotestosterone (DHT), a metabolite of testoster-
one (T), may be involved in certain aspects of androgen action in the ac-
cessory organs of the male reproductive system. In the adult male rat,
DHT formation from T occurs at appreciable rates only in known T tar-
get tissues [1,2]. Wilson and Lasnitzki reported, after following the ad-
ministration of radioactive T to intact animals, that the major fraction
of the isotope which is bound to the nuclei of the known target tissue
is in the form of DHT [2]. Both in vitro and in vivo studies have estab-
lished that DHT is equal or greater in potency to T itself [3,4]. To date,
long-term in vivo (12 months) delivery of DHT in a sustained manner
has not been investigated. Data obtained from previous studies has
shown that steroid (s) filled ceramic devices provide a unique delivery
system for delivering agent(s) of choice. The daily release rates of chem-
icals or biologicals (C/B) by subcutaneous or intraperitoneal implants
of ceramic reservoirs make it possible to provide a means of administer-
ing small but effective daily dosages over extended periods of time fol-
lowing implantation (SC or IP) of single or multiple ceramic capsule(s)
[5-11]. The purposes of this study were: (1) to compare the release rate
of dihydrotestosterone (DHT) from nonimpregnated and poly(lactic
acid) (PLA) impregnated ALCAP ceramic reservoirs implanted in male
rats, and (2) to study the effects of delivered DHT on the reproductive
systems of male rats.
MATERIALS AND METHODS
Ceramic Fabrication
ALCAP ceramic capsules were fabricated by calcining a mixture of
50:34:16 by weight of aluminum oxide, calcium oxide, and phospho-
rous pentoxide powders (Fisher Scientific Company, Fairlawn, ND) at
1350°C in a high temperature furnace (Thermolyne, Dubuque, Iowa)
for 12 h. The calcined material was ground in a roller mill and sieved
(Tyler Sieve Stacks) to obtain particles of 1-38 micrometers. The
ceramic particulate powder was then pressed into a hollow cylindrical
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form (green shape) using a 5/16&dquo; die set with the aid of a French Pres-
sure Cell (American Instrument Company, Silver Springs, MD). Me-
chanical strength of the &dquo;green shape&dquo; capsules was increased by sinter-
ing at 1400 ° C for 36 h. The calculated density of the 160 capsules used
in this study was 1.83 f S.D. 0.17 g/cm3. Porosity of the ceramic was
decreased by treatment of the ceramic with PLA. Impregnation of the
ceramic with PLA decreases the rate of release of steroids contained in
the implants [10,11]. Eighty sintered capsules were impregnated in
vacuo with a 2% wt/vol solution of PLA in chloroform for one h, then air
dried for 24 h. Polymer (PLA) impregnated and nonimpregnated ce-
ramic capsules were distributed into two groups of 80 each. Each ce-
ramic in group I was filled with 40 mg of DHT. Ceramics in group II
were left empty and served as sham controls. Each ceramic capsule was
sealed at both ends with Silastic Medical Adhesive, Silicon Type A
(Dow Corning, Midland, MI). Steroid-containing and empty ceramics
were sterilized by exposure to ethylene oxide gas for 72 h.
Animals and Housing
One hundred and twenty Sprague-Dawley male albino rats (250-
270 g) obtained from Holtz Co., Madison, WI, were acclimatized in the
animal facilities for two weeks prior to surgery. The rats were then dis-
tributed randomly into three groups of 40 each. Rats in group I were
implanted intraperitoneally (IP) with two ceramic capsules containing
DHT, one PLA impregnated ceramic implant and a second nonimpreg-
nated ceramic implant, group II (sham controls) rats were implanted
with two empty ceramic capsules, and group III rats (unimplanted con-
trols) were not implanted with ceramics. The combination of a PLA im-
pregnated ceramic and a nonimpregnated ceramic was used in an at-
tempt to deliver circulating levels of DHT that were appropriate for
inhibiting spermatogenesis. Inappropriately high DHT levels will
maintain spermatogenesis through a local action of the steroid and
spermatogenesis will not be inhibited if the DHT levels are too low. All
the animals in this investigation were kept on a 12 h day/night cycle
and fed Purina Rodent Lab Chow 5001 (Ralston Purina, St. Louis, MO),
and water ad libitum.
Implantation
Rats were anesthetized with sodium pentobarbital (Butler, Colum-
bus, OH) and their abdomens shaved and scrubbed with providone
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iodine. The sterilized ceramics were then inserted intraperitoneally
through a 1.5 cm right or left side incision in the abdominal wall. The
incisions in the abdominal muscle walls were then sutured with 3-0 gut
(Ethicon, NJ) and the skin closed with 9-mm wound clips. Standard
aseptic techniques were employed for all surgical processes. After im-
plantation, each rat was injected intramuscularly with 0.1 ml of
200,000 units/ml Penicillin G Procaine (Veticare, Baltimore, MD).
Collection of Tissues
Eight rats from each group were euthanized at one, three, six, nine,
and twelve months by an overdose of diethyl ether. All animals were
gravity perfused using a phosphate buffered saline (pH 7.35) rinse solu-
tion and glutaraldehyde/formaldehyde fixatives. The PBS rinsing solu-
tion was perfused for 10 min at a pressure 120 mm Hg until blanching
of the testes was observed. The rinsing solution was followed by fixative
solution I for 10 min and finally by fixative II for another 10 min. All
tissues were stored in a fixative solution prior to plastic embedding.
Steroid remaining in the ceramic capsules was removed by crushing
and agitating each ALCAP cylinder in a 75% wt/vol aqueous ethanol
solution. Steroid concentration in the ethanol solution was determined
by measuring absorbance at 201 nm. The data were analyzed by analy-
sis of variance at p < 0.05 using routine statistical procedures [Vax
system].
Sperm Number, Motility and Morphology
Epididymal fluid was collected from the cauda epididymis and the
vas deferens of each animal. A 5-Itl sample was pipeted into 3 ml of aer-
ated 37 ° C mammalian Ringer’s solution containing fructose. After
mixing, an aliquot was placed in a deep well slide beneath a coverglass
and sperm motion was recorded at 37 °C using an American Optics
Phase contrast microscope equipped with an Olympus OM-1 35-mm
camera. Spermatozoa were photographed at 360 fold magnification us-
ing an exposure length of 10 seconds. Duplicate photographs were
taken for each sample. Percent motility was determined by counting
the number of motile and immotile sperm. Sperm concentration was
determined by counting spermatozoa in a 1:200 dilution of the original
sample using a hemocytometer. The spermatozoa were counted in the
center and four corner 0.2 mm squares of the central square millimeter
of the hemocytometer (total volume, 0.02 mm3).
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Spermatozoa Morphology
A sperm smear was fixed with formalin and stained with Giemsa.
Phase contrast photomicrographs were taken using an Olympus CH
light microscope equipped with an Olympus OM-1 35-mm camera.
Radioimmunoassay
Blood was collected by cardiac puncture prior to the sacrifice of the
animal. The blood was allowed to set for one h at room temperature.
The erythrocytes were removed by centrifugation at 1600 x g for 10
min. Serum was decanted and frozen until analyzed. Radioimmuno-
assay for testosterone (T), luteinizing hormone (LH), and follicle-stimu-
lating hormone (FSH) were conducted using standard protocols (Cen-
tral Ligand Assay Labs, The University of Michigan, Ann Arbor, MI).
RESULTS AND DISCUSSION
Shown in Figure 1 are the release rates of DHT from PLA impreg-
nated and nonimpregnated ALCAP ceramics implanted in rats for the
12 month duration of the study. The rate of release of DHT from nonim-
pregnated ceramics was significantly higher than that of PLA impreg-
nated ceramics. Data obtained from previous studies [5] support the
concept that impregnation of the ceramics decreases the delivery rate
of various drugs by blocking or reducing the size of macropores in the
Figure 1. The delivery profiles (~g/day/rat t SD) of dihydrotestosterone released from
PLA-impregnated ALCAP (I-ALCAP) nommpregnated ALCAP (N-ALCAP) ceramic cap-
sules implanted in male rats
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ceramic implant. Since the steroids were stored in a powdered state
within the ceramic reservoir, the mechanism of release from the reser-
voirs probably involves diffusion of the abdominal fluid into the ce-
ramic reservoir, dissolution of the steroid powders, and exit of the dis-
solved steroid through the ceramic pores. Erosion of the ceramic in
vivo, because of its biodegradability, serves to enhance the rate of
steroid release over time by increasing the size of the macropores in the
ceramic. Impregnation with PLA probably reduces the rate of erosion
of the ceramic and maintains a smaller pore size resulting in less
steroid delivered and thereby lengthens the interval of steroid release
from the implant. Scanning electron photomicrographs of representa-
tive ceramics retrieved at the end of several phases, confirmed that the
degree of biodegradation of the ceramics was directly proportional to
the duration of implantation. In comparison to in vitro rate of release,
the rate of DHT released in vivo was slower by a factor of 12. According
to our previous reports, the slow release of DHT in vivo could be due to:
(1) high viscosity of abdominal fluid and low solubility of steroid in that
fluid in comparison to the 50% aqueous ethanol solution used in the in
vitro experiments, (2) inhibition of materials transport out of the ce-
ramic because of the formation of a fibrous capsule around the implant,
and (3) maintenance of a uniform pore size under in vitro conditions.
The mean weights ot’ accessory sex organs are shown in Figure 2. A
significant regression in testes weight was observed following 30 days
of implantation. This significant reduction in the relative testicular
weight continued up to 12 months. The reduction in testicular mass is
probably due to the effects of DHT delivered by ALCAP ceramics on the
hypothalamic system and the resultant decrease in secretion of gonado-
trophins and inhibition of local production of endogenous testosterone.
Histological and histopathological evaluations (Figure 2a) revealed
that at the end of one month the physiological changes observed were:
decreased tubular diameters, arrested spermatogenesis, and decreased
production of spermatozoa (oligospermia). Three months after the im-
plantation of DHT containing ceramic capsules, spermatozoa could not
be detected in the seminiferous tubules of the rat testes (azoospermia).
In adult animals treated with DHT, suppression of spermatogenesis
has been shown to be associated with a decrease in circulating levels of
testosterone [13]. In castrated rats, administration of DHT results in
restoring and maintaining the weights of accessory sex organs [14]. Re-
sults of this investigation confirm previous findings and suggest that
the decrease in spermatogenic activity could be due to suppression of
gonadotrophins and consequent decrease in intratesticular testos-
terone.
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Figure 2. Reproductive organ weights (mean t SD) of male control rats, male rats im-
planted with two empty &dquo;sham&dquo; ALCAP capsules, and male rats implanted with PLA im-
pregnated (I-ALCAP) and nonimpregnated ALCAP (N-ALCAP) ceramic capsules contain-
ing DHT (40 mg each) for treatment periods of 3, 6, 9, and 12 months.
Shown in Figure 2 are the weights of epididymis (head-body), ob-
tained from rats implanted with DHT filled ALCAP ceramics. These
were significantly different than epididymis obtained from shams and
intact control rats. Since DHT is the only nuclear bound androgen in
the rat epididymis, the reduction in epididymal mass could be due to
the low endogenous DHT levels. Histopathological evaluations (Fig-
ures 2b-2d) of testes and accessory organs in this study suggest that
the suppression of epididymal mass may be due to the decreased
growth of the epididymal ducts (Figure 2b). Epididymal fluid analy-
sis showed that DHT released from ALCAP ceramics induced oligo-
spermia in rats after one month, and that the azoospermia achieved at
the end of three months was maintained up to 12 months. These obser-
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Figure 2a. Photographs of representative cross-sections of testes from male control rats
(top), and male rats implanted with PLA impregnated and nommpregnated ALCAP
ceramics capsules containing DHT (40 mg) (bottom) for a treatment period of 6 months
( x 160)
Figure 2b. Photographs of representative cross-sections of epididymis from intact male
control rats (a), and male rats implanted with PLA impregnated and nommpregnated
ALCAP ceramic capsules containing 40 mg DHT (b) each for a treatment period of 6
months (x 160)
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Figure 2c. Representative cross-section of semmal vesicles from intact male control rats
(a), and intact male rats implanted with PLA impregnated and nonimpregnated ALCAP
ceramic capsules containing 40 mg DHT (b) each for treatment period of 6 months
( x 160).
Figure 2d. Representative cross-section of prostates from intact male control rats (a), and
intact male rats implanted with PLA impregnated and nommpregnated ALCAP ceramic
capsules containing 40 mg DHT lb) each for treatment period of 6 months (x 160).
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vations were supported by data obtained from hormonal blood analysis.
In comparison to circulating LH and FSH levels of sham and control
rats, the serum LH and FSH levels of experimental rats decreased sig-
nificantly for the entire duration of the study (Figure 3). Serum T levels
of experimental rats were significantly lower than the serum T levels of
sham and control rats. Increase in age was associated with a decrease
in serum T levels in all rats. It seems that the decrease in endogenous
T level eventually leads to a decrease in both testicular and epididymal
mass. The results of this study suggest that the use of nonimpregnated
and PLA impregnated ceramic capsules, loaded with 40 mg DHT each,
are adequate to induce azoospermia in rats. Results of previous experi-
Figure 3. Testosterone, LH and FSH levels in serum obtained from male control rats,
male rats implanted with two empty &dquo;sham&dquo; ALCAP capsules and male rats implanted
with PLA impregnated and nonimpregnated ALCAP ceramic capsules containing DHT
(40 mg) for treatment periods of 1, 3, 6, 9 and 12 months.
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ments in our laboratory have revealed that ceramic capsules designed
to release 211 ~,g/day DHT in rats were capable of achieving oligo-
spermia but not azoospermia. It was also observed that ceramics fabri-
cated to release 512 jlg/day DHT were capable of maintaining sperma-
togenesis and compensating for the lack of endogenous androgens
produced by the testes. Shown in Figure 2 are the weights of prostates
in experimental rats. These were regressed at the end of the three
months post-implantation in comparison to sham and control groups.
At the end of six, nine, and twelve month intervals, the weights of the
seminal vesicles and ventral prostates in experimental rats were not
significantly different from those of sham and control rats. Several in-
vestigators have reported that the growth of the prostate in rats is stim-
ulated by DHT, and it appears that DHT is the principal intracellular
androgen of the prostate [15-19]. The role of DHT in human prostatic
growth is supported by the fact that absence of significant prostatic de-
velopment is seen in subjects who have a deficiency of the enzyme
5-alpha-reductase in the presence of high levels of circulating T [15-
191. Results of this investigation (Figure 2d) show that the amount of
DHT released from ALCAP ceramics was capable of maintaining the
normal function of prostatic tissues.
The effect of sustained release of appropriate amounts of DHT from
ceramics on other vital tissues was also examined. There were no sig-
nificant differences between the weights of the kidneys and adrenals
obtained from experimental, sham, and control rats (Figure 4). The
spleen, heart, and body weight were unaffected by the amount of DHT
released from the ceramic implants (Figures 4 and 5).
CONCLUSIONS
The overall observations made during this investigation suggest
that: (1) nonimpregnated and PLA impregnated ALCAP ceramic cap-
sules can be used to deliver DHT in a sustained manner for long dura-
tions (12 months), in amounts capable of eliciting some physiological
responses. (2) Slow release of DHT from ALCAP ceramics in vivo can be
achieved by impregnating the ceramic capsules with PLA. (3) The use
of two DHT filled ceramic capsules in rats (one nonimpregnated and
one impregnated with PLA) can induce oligospermia after one month
and maintain azoospermia for 3-12 months. (4) DHT, administered by
the use of ceramic drug delivery systems, does not induce changes in
the body weights and the weights of major vital organs. (5) Dihydrotes-
tosterone delivered by ALCAP capsules can be used effectively to regu-
late spermatogenesis in rats.
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Figure 4. Vital organ weights (mean + ) of male control rats, male rats implanted with
two empty &dquo;sham&dquo; ALCAP capsules, and male rats implanted with PLA impregnated and
nommpregnated ALCAP ceramic capsules containing DHT (40 mg) for treatment periods
of 3, 6, 9 and 12 months
Figure 5. Body weights of male control rats, male rats implanted with two empty &dquo;sham&dquo;
ALCAP capsules and male rats implanted with PLA impregnated and nonimpregnated
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